- Pieris Pharmaceuticals (NASDAQ:PIRS): Q1 GAAP EPS of -$0.07 beats by $0.10.
- Revenue of $15.63M (+17.9% Y/Y) beats by $9.93M.
- Press Release
Pieris Pharmaceuticals EPS beats by $0.10, beats on revenue
Recommended For You
More Trending News
About PIRS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PIRS | - | - |
Pieris Pharmaceuticals, Inc. |